Feng Chi Biotech Corp. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 178.906 million compared to TWD 174.328 million a year ago. Operating income was TWD 28.583 million compared to TWD 20.098 million a year ago. Net income was TWD 25.393 million compared to TWD 17.358 million a year ago. Basic earnings per share was TWD 1.65 compared to TWD 1.16 a year ago. Diluted earnings per share was TWD 1.64 compared to TWD 1.16 a year ago.